These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8426365)
1. Novel 6-alkoxypurine 2',3'-dideoxynucleosides as inhibitors of the cytopathic effect of the human immunodeficiency virus. Burns CL; St Clair MH; Frick LW; Spector T; Averett DR; English ML; Holmes TJ; Krenitsky TA; Koszalka GW J Med Chem; 1993 Feb; 36(3):378-84. PubMed ID: 8426365 [TBL] [Abstract][Full Text] [Related]
2. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum. Singhal D; Ho NF; Anderson BD J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907 [TBL] [Abstract][Full Text] [Related]
3. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats. Singhal D; Morgan ME; Anderson BD Pharm Res; 1997 Jun; 14(6):786-92. PubMed ID: 9210198 [TBL] [Abstract][Full Text] [Related]
4. Localization of purine metabolizing enzymes in bovine brain microvessel endothelial cells: an enzymatic blood-brain barrier for dideoxynucleosides? Johnson MD; Anderson BD Pharm Res; 1996 Dec; 13(12):1881-6. PubMed ID: 8987089 [TBL] [Abstract][Full Text] [Related]
5. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides. Johns DG; Ahluwalia GS; Cooney DA; Mitsuya H; Driscoll JS Mol Pharmacol; 1993 Sep; 44(3):519-23. PubMed ID: 8371712 [TBL] [Abstract][Full Text] [Related]
6. Optimization of the local inhibition of intestinal adenosine deaminase (ADA) by erythro-9-(2-hydroxy-3-nonyl)adenine: enhanced oral delivery of an ADA-activated prodrug for anti-HIV therapy. Singhal D; Anderson BD J Pharm Sci; 1998 May; 87(5):578-85. PubMed ID: 9572908 [TBL] [Abstract][Full Text] [Related]
7. Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides. Murakami K; Shirasaka T; Yoshioka H; Kojima E; Aoki S; Ford H; Driscoll JS; Kelley JA; Mitsuya H J Med Chem; 1991 May; 34(5):1606-12. PubMed ID: 2033586 [TBL] [Abstract][Full Text] [Related]
8. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats. Singhal D; Morgan ME; Anderson BD Drug Metab Dispos; 1996 Oct; 24(10):1155-61. PubMed ID: 8894519 [TBL] [Abstract][Full Text] [Related]
9. Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro. Shirasaka T; Murakami K; Ford H; Kelley JA; Yoshioka H; Kojima E; Aoki S; Broder S; Mitsuya H Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9426-30. PubMed ID: 2251284 [TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of new anti-HIV agents: 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine. Russell JW; Klunk LJ Biochem Pharmacol; 1989 May; 38(9):1385-8. PubMed ID: 2497744 [TBL] [Abstract][Full Text] [Related]
11. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity. Daluge SM; Good SS; Faletto MB; Miller WH; St Clair MH; Boone LR; Tisdale M; Parry NR; Reardon JE; Dornsife RE; Averett DR; Krenitsky TA Antimicrob Agents Chemother; 1997 May; 41(5):1082-93. PubMed ID: 9145874 [TBL] [Abstract][Full Text] [Related]
12. Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats. Anderson BD; Morgan ME; Singhal D Pharm Res; 1995 Aug; 12(8):1126-33. PubMed ID: 7494823 [TBL] [Abstract][Full Text] [Related]
13. Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase. DeGraw RT; Anderson BD Pharm Res; 2001 Sep; 18(9):1270-6. PubMed ID: 11683239 [TBL] [Abstract][Full Text] [Related]
14. C(2')-substituted purine nucleoside analogs. Interactions with adenosine deaminase and purine nucleoside phosphorylase and formation of analog nucleotides. Stoeckler JD; Bell CA; Parks RE; Chu CK; Fox JJ; Ikehara M Biochem Pharmacol; 1982 May; 31(9):1723-8. PubMed ID: 6809009 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of the anti-HIV-1 activity of ddAdo by coformycin, EHNA and deaza-EHNA derivatives. Marongiu ME; Pani A; Tinti E; Grifantini M; Franchetti P; Cristalli G; La Colla P New Microbiol; 1995 Oct; 18(4):359-70. PubMed ID: 8590388 [TBL] [Abstract][Full Text] [Related]
17. Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro. Baba M; Pauwels R; Balzarini J; Herdewijn P; De Clercq E; Desmyter J Antimicrob Agents Chemother; 1987 Oct; 31(10):1613-7. PubMed ID: 3435108 [TBL] [Abstract][Full Text] [Related]
18. Potentiating effect of (2-[2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methyl]-phenyl]ethenyl) -phosphonic acid (MDL 74,428), a potent inhibitor of purine nucleoside phosphorylase, on the antiretroviral activities of 2',3'-dideoxyinosine combined with ribavirin in mice. Weibel M; Balzarini J; Bernhardt A; Mamont P Biochem Pharmacol; 1994 Jul; 48(2):245-52. PubMed ID: 8053921 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-HIV activity of carbocyclic 2',3'-didehydro-2',3'-dideoxy 2,6-disubstituted purine nucleosides. Vince R; Hua M J Med Chem; 1990 Jan; 33(1):17-21. PubMed ID: 2296018 [TBL] [Abstract][Full Text] [Related]
20. Metabolism in human leukocytes of anti-HIV dideoxypurine nucleosides. Fridland A; Johnson MA; Cooney DA; Ahluwalia G; Marquez VE; Driscoll JS; Johns DG Ann N Y Acad Sci; 1990; 616():205-16. PubMed ID: 2078020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]